Reumofan Plus Tablets, 30-count bottle per Box, (remaining label information in Spanish)
Published December 5, 2012 · Recall initiated: August 27, 2012
Summary
FDA records drug Class I recall D-063-2013, published December 5, 2012 and initiated August 27, 2012. Recalling firm: Samantha Lynn, Inc; Status: Terminated; Reported quantity: 25,888 Boxes; Lot: all lots within expiry through 2016. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an approved NDA/ANDA: Samantha Lynn Inc. is recalling Reumofan Plus Tablets because it contains undeclared drug ingredients making it an unapproved drug.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Samantha Lynn, Inc
- Distributor
- Nationwide and Canada, Australia, Germany, Brazil, Austria, United Kingdom, India, Chile, Switzerland, Thailand, Japan
- Lot
- all lots within expiry through 2016
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAdvair HFA (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol, 12g, 120 MeteredDecember 5, 2012
- FDAAdvair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg 60 Actuations INST, NDCDecember 5, 2012
- FDAMylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505December 5, 2012
- FDASenTec V-Sign Membrane Changer Insert (VS-MCI), 5 pieces. The SenTec V-Sign Membrane Changer Insert isNovember 28, 2012
- FDASenTec V-Sign Membrane Changer (VS-MC), 9 pieces. The SenTec V-Sign Membrane Changer is indicated for use withNovember 28, 2012
- FDA4.5mm PLEO Osteotomy Guide. OrthoPediatrics Corp. markets a pediatric, extension osteotomy bone plate system.November 28, 2012
Questions about this recall
Was Reumofan Plus Tablets, 30-count bottle per Box, (remaining label information in Spanish) recalled?
Yes. FDA published recall D-063-2013 on December 5, 2012. Reported hazard: Marketed without an approved NDA/ANDA: Samantha Lynn Inc. is recalling Reumofan Plus Tablets because it contains undeclared drug ingredients making it an unapproved drug.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release